334 related articles for article (PubMed ID: 30912042)
1. Production and Validation of Lentiviral Vectors for CRISPR/Cas9 Delivery.
Ryø LB; Thomsen EA; Mikkelsen JG
Methods Mol Biol; 2019; 1961():93-109. PubMed ID: 30912042
[TBL] [Abstract][Full Text] [Related]
2. Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology.
Qiu Y; Ding Q
STAR Protoc; 2021 Mar; 2(1):100307. PubMed ID: 33554142
[TBL] [Abstract][Full Text] [Related]
3. Simple CRISPR-Cas9 Genome Editing in Saccharomyces cerevisiae.
Laughery MF; Wyrick JJ
Curr Protoc Mol Biol; 2019 Dec; 129(1):e110. PubMed ID: 31763795
[TBL] [Abstract][Full Text] [Related]
4. Construction of an Inducible CRISPR/Cas9 System for CXCR4 Gene and Demonstration of its Effects on MKN-45 Cells.
Peng Y; Yang T; Tang X; Chen F; Wang S
Cell Biochem Biophys; 2020 Mar; 78(1):23-30. PubMed ID: 31875277
[TBL] [Abstract][Full Text] [Related]
5. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-Mediated Genome Editing for Huntington's Disease.
Vachey G; Déglon N
Methods Mol Biol; 2018; 1780():463-481. PubMed ID: 29856031
[TBL] [Abstract][Full Text] [Related]
7. Genome Editing: CRISPR-Cas9.
Hoof JB; Nødvig CS; Mortensen UH
Methods Mol Biol; 2018; 1775():119-132. PubMed ID: 29876814
[TBL] [Abstract][Full Text] [Related]
8. Efficient Cas9 multiplex editing using unspaced sgRNA arrays engineering in a Potato virus X vector.
Uranga M; Aragonés V; Selma S; Vázquez-Vilar M; Orzáez D; Daròs JA
Plant J; 2021 Apr; 106(2):555-565. PubMed ID: 33484202
[TBL] [Abstract][Full Text] [Related]
9. Design and Assembly of CRISPR/Cas9 Lentiviral and rAAV Vectors for Targeted Genome Editing.
Sandoval IM; Collier TJ; Manfredsson FP
Methods Mol Biol; 2019; 1937():29-45. PubMed ID: 30706388
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.
Dong W; Kantor B
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372494
[TBL] [Abstract][Full Text] [Related]
11. Heritable CRISPR-Cas9 editing of plant genomes using RNA virus vectors.
Uranga M; Aragonés V; Daròs JA; Pasin F
STAR Protoc; 2023 Mar; 4(1):102091. PubMed ID: 36853698
[TBL] [Abstract][Full Text] [Related]
12. A simple, flexible and high-throughput cloning system for plant genome editing via CRISPR-Cas system.
Kim H; Kim ST; Ryu J; Choi MK; Kweon J; Kang BC; Ahn HM; Bae S; Kim J; Kim JS; Kim SG
J Integr Plant Biol; 2016 Aug; 58(8):705-12. PubMed ID: 26946469
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 as a tool to dissect cancer mutations.
Sayed S; Paszkowski-Rogacz M; Schmitt LT; Buchholz F
Methods; 2019 Jul; 164-165():36-48. PubMed ID: 31078796
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 mediated targeting of multiple genes in Dictyostelium.
Sekine R; Kawata T; Muramoto T
Sci Rep; 2018 May; 8(1):8471. PubMed ID: 29855514
[TBL] [Abstract][Full Text] [Related]
15. A Single Transcript CRISPR-Cas9 System for Multiplex Genome Editing in Plants.
Tang X; Zhong Z; Ren Q; Liu B; Zhang Y
Methods Mol Biol; 2019; 1917():75-82. PubMed ID: 30610629
[TBL] [Abstract][Full Text] [Related]
16. A lentivirus-based system for Cas9/gRNA expression and subsequent removal by Cre-mediated recombination.
Carpenter MA; Law EK; Serebrenik A; Brown WL; Harris RS
Methods; 2019 Mar; 156():79-84. PubMed ID: 30578845
[TBL] [Abstract][Full Text] [Related]
17. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
[TBL] [Abstract][Full Text] [Related]
18. Gene Disruption Using CRISPR-Cas9 Technology.
Hu N; Malek SN
Methods Mol Biol; 2019; 1881():201-209. PubMed ID: 30350208
[TBL] [Abstract][Full Text] [Related]
19. Efficient viral delivery of Cas9 into human safe harbor.
Hayashi H; Kubo Y; Izumida M; Matsuyama T
Sci Rep; 2020 Dec; 10(1):21474. PubMed ID: 33293588
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-Mediated Genome Editing in Epstein-Barr Virus-Transformed Lymphoblastoid B-Cell Lines.
Jiang S; Wang LW; Walsh MJ; Trudeau SJ; Gerdt C; Zhao B; Gewurz BE
Curr Protoc Mol Biol; 2018 Jan; 121():31.12.1-31.12.23. PubMed ID: 29337376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
